Evidence map›Paper›PMID 41862755›Full record

ArticleOral and maxillofacial surgery2026

When reconstruction isn't the end: Late-occurring ameloblastoma in a fibula-grafted mandible.

Doha Revend, Lawik Revend, Adrian Zu Knyphausen, Anna Aydin, Oliver Schuck, Stephanie Roj, Johannes Schunk, Manfred Giese, Florian Dudde

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Oral and maxillofacial surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Doha Revend *Department of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Lawik Revend *Department of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Adrian Zu KnyphausenMVZ Medizinisches Labor Nord, Institute of Pathology, Hamburg, Germany.
Anna AydinDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Oliver SchuckDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Stephanie RojDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Johannes SchunkDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Manfred GieseDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany.
Florian DuddeDepartment of Oral and Maxillofacial Surgery, Army Hospital Hamburg, Lesserstraße 180, D-22049, Hamburg, Germany. floriandudde@gmx.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmeloblastomas are rare odontogenic tumors with a high tendency for local recurrence, particularly in previously operated or reconstructed jaws. Late manifestations decades after initial therapy are extremely uncommon and pose diagnostic as well as surgical challenges. CASE PRESENTATION: We present the case of a 90-year-old woman with a history of squamous cell carcinoma of the mandible, treated decades earlier by segmental resection and microvascular fibula graft reconstruction. After nearly three decades of clinical stability, the patient developed bilateral mandibular masses with progressive symptoms including submental swelling and lip paresthesia. Imaging revealed two osteolytic lesions adjacent to, but not involving, the fibula graft. Histopathological examination confirmed a conventional follicular ameloblastoma without cytological atypia. Molecular profiling showed a BRAF-wildtype genotype. Surgical resection was performed bilaterally, preserving the structurally intact fibula flap on the left side. The postoperative course was uneventful with functional recovery and no signs of recurrence at three-month follow-up.

conclusionThis case illustrates the potential for extremely late-onset ameloblastomas in reconstructed mandibles and emphasizes the importance of lifelong follow-up in patients with a history of mandibular malignancy. It also highlights the value of molecular diagnostics in therapy planning and demonstrates that preserving existing grafts during revision surgery can offer oncologically sound and functionally superior outcomes in selected elderly patients.

Indexed as

AmeloblastomaBone TransplantationCarcinoma, Squamous CellFibulaMandibular NeoplasmsMandibular ReconstructionAged, 80 and overFemaleHumansAmeloblastomaHead and Neck CancerMandibleOncologic TreatmentSquamous Cell Carcinoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.